Abstract
Purpose
The purpose of this study is to help predict the prognosis of multiple osteochondromatosis patients with the investigation of social function, pain, physical function and quality of life of patients.
Materials and Methods
Forty-five cases were diagnosed as multiple osteochondromatosis from March 1993 to June 2014. We performed a survey on pain, daily life, school or work life assessment of research and development-36. Forty-five people who responded to the survey completely were enrolled. Variable factors, including physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health state were considered as elements related to quality of life. In addition, we investigated significant factors for multiple osteochondromatosis patients, and analyzed the survey by scoring. Related factors included age (over 18 years and under 18 years), gender, body mass index, operation, joint deformity, recurrence of disease, family history, the number of involved joints and the location of tumor. Statistical analyses were performed using SAS ver. 9.3 (SAS Inc., Cary, NC, USA). p-values of <0.05 were deemed statistically significant.
Results
Patients with a family history of multiple osteochondromatosis showed a significantly decreased result of assessment, physical function, vitality of life, social activities, and health state. In addition, there was a tendency of a poor influence in pain, emotional wellbeing, and general health.
Conclusion
The results suggest that family history is a significant factor influencing and predicting the quality of life. In other words, the developed patients in the household including patients with severe enough for the rest of the family to know have poor prognosis. Through this study multiple osteochondromatosis is a chronic disease having a profound impact on quality of life.
Figures and Tables
References
1. Legeai-Mallet L, Munnich A, Maroteaux P, Le Merrer M. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet. 1997; 52:12–16.
2. Wicklund CL, Pauli RM, Johnston D, Hecht JT. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995; 55:43–46.
3. Sugiura Y, Sugiura I, Iwata H. Hereditary multiple exostosis: diaphyseal aclasis. Jinrui Idengaku Zasshi. 1976; 21:149–167.
4. Xiao CY, Wang J, Zhang SZ, et al. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis. Br J Cancer. 2001; 85:176–181.
5. Schmale GA, Conrad EU 3rd, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994; 76:986–992.
6. Bovée JVMG, Hogendoorn PCW. Multiple osteochondromas. In : Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press;2002. p. 360–362.
7. Khurana J, Abdul-Karim F, Bovée JVMG. Osteochondroma. In : Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press;2002. p. 234–236.
8. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 10. Health Econ. 1993; 2:217–227.
9. VanderZee KI, Sanderman R, Heyink JW, deHaes H. Psychometric qualities of the RAND 36-item Health Survey 10: a multidimensional measure of general health status. Int J Behav Med. 1996; 3:104–122.
10. Hair JF, Anderson RE, Tatham RL, Black W. Black multivariate data analysis. 5th ed. New Jersey: Prentice hall;1998. p. 141–213.